专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明公开

KR1020000049050A 술폰아미드 치환된 아스파르트산 인터루킨-1β 전환 효소 억제제 无效
标题翻译：磺酰胺取代的ASPACTIC ACID INTERLEUKIN-1 BETA转换酶抑制剂
公开(公告)号：KR1020000049050A
公开(公告)日：2000-07-25
申请号：KR1019997003119
申请日：1997-10-09
申请人： 워너-램버트 캄파니 엘엘씨 , 바스프 에스이
发明人： 알렌,해미쉬,존 , 브래디,케니쓰,데일 , 하터,윌리암,글렌 , 루니,엘리자베쓰,앤 , 플러머,마크,스티븐 , 소워,토미 , 샤리푸어,오래쉬 , 워커,니겔
IPC分类号： C07C311/29
CPC分类号： C07D307/12 , C07C311/19 , C07C311/29 , C07C311/46 , C07C323/67 , C07C2601/14 , C07C2602/10
摘要： PURPOSE: Provided are compounds which are inhibitors of interleukin- I p converting enzyme. Also provided is a method of treatment of stroke, inflammatory diseases, septic shock, reperfusion injury, Alzheimer's disease, shigellosis, and to a pharmaceutically acceptable composition that contains a compound that is an inhibitor of interleukin-1P converting enzyme. CONSTITUTION: Compounds are illustrated by the Formula I wherein R1 is hydrogen, C1-C6alkyl, or benzyl; R2 is -CHO, -CORa, or -CN; each Ra is independently hydrogen or Cl-C6alkyl; X is a bond, CH2, CHR5, NH, NR5, or O; R3 is aryl, substituted-aryl, heteroaryl, substituted-heteroaryl, cycloalkyl, substituted-cycloalkyl, heterocycle, or substituted-heterocycle; Y is absent, NR5, CO, S, O, SO2, -o(CHR5)n-, CHR5, NR5CO, CONR5, OCHR5, CHR5O, SCHR5, CHR5S, SO2NR5, C1-C6alkyl, NR5SO2, CH2CHR5, CHR5CH2, COCH2, or CH2CO; R4 is absent, aryl, substituted-aryl, Cl-Cgalkyl, heteroaryl, substituted-heteroaryl, cycloalkyl, Cl-C6alkyl, substituted-cycloalkyl, heterocycloalkyl, or substituted-heterocycloalkyl; each R5 is independently hydrogen, C1-C6alkyl, aryl, -(CH2)naryl, or -(CH2)ncycloalkyl; each n is independently 0 to 5, m is 1 or 2, and the pharmaceutically acceptable salts, esters, amides, and prodrugs thereof.
摘要翻译：目的：提供作为白细胞介素-I p转换酶抑制剂的化合物。还提供了治疗中风，炎性疾病，败血性休克，再灌注损伤，阿尔茨海默病，志贺氏菌病的方法，以及含有作为白细胞介素-1P转化酶抑制剂的化合物的药学上可接受的组合物。构成：化合物由式I表示，其中R 1是氢，C 1 -C 6烷基或苄基; R2是-CHO，-CORa或-CN; 每个R a独立地是氢或C 1 -C 6烷基; X是键，CH2，CHR5，NH，NR5或O; R 3为芳基，取代芳基，杂芳基，取代杂芳基，环烷基，取代环烷基，杂环或取代杂环; Y不存在，NR 5，CO，S，O，SO 2，-o（CHR 5）n - ，CHR 5，NR 5 CO，CONR 5，OCHR 5，CHR 5 O，SCHR 5，CHR 5 S，SO 2 NR 5，C 1 -C 6烷基，NR 5 SO 2，CH 2 CHR 5，CHR 5 CH 2，COCH 2，或CH 2 CO; R 4不存在，芳基，取代的芳基，C 1 -C 8烷基，杂芳基，取代的杂芳基，环烷基，C 1 -C 6烷基，取代的环烷基，杂环烷基或取代的 - 杂环烷基; 每个R 5独立地是氢，C 1 -C 6烷基，芳基， - （CH 2）n芳基或 - （CH 2）n环烷基; 每个n独立地为0至5，m为1或2，以及其药学上可接受的盐，酯，酰胺和前药。

IPRDB

热门服务

关于我们

友情链接

联系方式